news & events
portfolio news
12.06.18
Vivet Therapeutics Appoints Eduardo Bravo as New Chairman of the Board
10.05.18
BioClin Therapeutics, Inc.,Completes $50 Million Series B Financing with Addition of New Investors
03.04.18
CorWave is set to receive about €3 million in financing through France’s Worldwide Innovation Challenge for its NovaPulse program, a mini-invasive solution for cardiac support
16.03.18
Lundbeck to acquire Prexton Therapeutics adding foliglurax in clinical phase II to its pipeline of innovative treatments for patients suffering from Parkinson’s disease
15.03.18
OxThera announces the randomization of the first patient into its phase III EPHEX study with Oxabact
09.03.18
AM-Pharma announces Phase II study results of recAP in sepsis-associated Acute Kidney Injury
06.03.18
Sanifit Announces Results of the Phase II Clinical Trial of SNF472 in Patients with Calciphylaxis
05.03.18
Kala Pharmaceuticals Appoints Gregory Perry to Board of Directors and as Audit Committee Chair
20.02.18
Minoryx Therapeutics spins off SEE-Tx platform into new company, Gain Therapeutics
31.01.18
QIAGEN enters into agreement to acquire STAT-Dx, plans to launch a next-generation, fully integrated multiplex platform for syndromic disease testing
